CAMOSUNATE

This brand name is authorized in Nigeria.

Active ingredients

The drug CAMOSUNATE contains a combination of these active pharmaceutical ingredients (APIs):

1	Artesunate UNII 60W3249T9M - ARTESUNATE
	Artesunate is a semi-synthetic artemisinin derivative, indicated for the initial treatment of severe malaria in adults and children. The antimalarial mechanism of action of artesunate is generally thought to depend upon activation involving iron-mediated cleavage of the endoperoxide bridge of DHA to generate an unstable organic free radical followed by alkylation, where the free radical binds to malarial proteins leading to destruction of parasite membranes.
	Read more about Artesunate
2	Amodiaquine UNII K6PW2S574L - AMODIAQUINE HYDROCHLORIDE
	Read more about Amodiaquine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BF03	Artesunate and amodiaquine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-7908
Switch country to Nigeria in order to find specific presentations of CAMOSUNATE